Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial DNA and RNA synthesis machinery is a coordinated system of enzymes and proteins essential for the replication and expression of the bacterial genome [1.1.1, 1.1.2]. This machinery includes the replisome, which carries out DNA replication through the actions of DNA polymerases, helicases, primases, and topoisomerases like DNA gyrase and topoisomerase IV [1.1.2, 1.2.4]. It also includes the transcription complex, centered around DNA-dependent RNA polymerase (RNAP), which synthesizes various RNA species required for protein production [1.1.1, 1.2.1]. These processes are fundamental to bacterial cell division and survival, making them highly effective targets for a wide range of antibiotics [1.1.3, 1.3.1]. Fluoroquinolones, for instance, target topoisomerases to induce lethal DNA strand breaks, while rifamycins bind to RNAP to halt transcription [1.2.1, 1.2.4]. The structural divergence between bacterial and eukaryotic nucleic acid synthesis components provides a basis for selective toxicity in treating infections [1.2.1, 1.3.1]. However, the clinical utility of drugs targeting this machinery is frequently challenged by the emergence of resistance mutations in the genes encoding these enzymes [1.2.1, 1.2.5]. Understanding the structural and functional nuances of this machinery is critical for the development of next-generation antimicrobials to combat multi-drug resistant pathogens [1.1.2, 1.2.5].
Inhibition of DNA gyrase and topoisomerase IV to prevent DNA replication; inhibition of DNA-dependent RNA polymerase to block transcription; induction of DNA damage; and inhibition of nucleotide precursor synthesis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA and RNA synthesis machinery.